Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
26 April, 2024 16:40 IST
TCS to see 1.5% q-o-q USD revenue growth: Religare
Source: IRIS | 15 Dec, 2014, 11.56AM
Rating: NAN / 5 stars.
Comments  |  Post Comment

Religare Research maintained 'Buy' on Tata Consultancy Services (TCS) with target price of Rs 2,860 in its report.

Commenting on the investment rationale, the stock broker said, "Geographically, Europe (ex-UK) and India will be strong, while the US would be in line with company expectations. Within verticals, retail, manufacturing and hi-tech are being hit by shutdowns, while insurance is showing higher thanexpected weakness. Further, sharp Euro and GBP movements against the USD will pull down USD revenue growth by 220bps QoQ. Overall, we expect TCS to see 1.5% QoQ USD revenue growth, below expectations."

"While there are no project deferments so far, the sentiment is softer than same time last year. Select smaller verticals are seeing traction but large verticals will be a drag. While energy is stable so far, weakness in oil prices could weigh on the vertical. Realisations however could see some uptick led by mix shifts.

Operationally, management expects Q3 margins to remain flat, though there could be some benefits due to FX movements. Overall, management maintained its near-term operating margin target of 26-28%. While forex gains would be higher in the quarter, treasury income is likely to be lower."

Weak commentary is a negative surprise for the street and will weigh on the stock in the near term. "We cut our FY15/FY17 EPS estimates by 1.5%/1% to factor in a weaker Q3 and the FX impact. We expect TCS to still grow ahead of industry, and valuations at 16.5x FY17E are reasonable. Clarity on CY15 budgets and commentary on FY16 will be the key share price drivers," Religare added.

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.

 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer